Navigation Links
Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt

Geneticist Fred Alt will be awarded the 44th Rosenstiel Award for Distinguished Work in Biomedical Science by Brandeis University for his pioneering research exploring the mechanisms of genomic instability and its implications for the immune system and cancer cells. Alt is the second alumnus to win the Rosenstiel Award; the first, Rod McKinnon, won the Nobel Prize in 2003.

Alt is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School and an investigator at the Howard Hughes Medical Institute at Boston Children's Hospital. He also directs the program in cellular molecular medicine at Children's Hospital Boston.

Sometimes it pays to have genomic rearrangements. In a healthy immune system, antibody genes are purposefully mutated, broken and recombined by programmed mechanisms in order to diversify and strengthen the immune response. But sometimes, this process can go wrong and result in chromosomal abnormalities and cancers such as leukemias and lymphomas.

Alt explores the mechanisms by which particular gene regions are activated for rearrangement and how distant broken DNA segments are joined together, both in healthy immune systems and deadly cancer cells. In four decades in the lab, Alt's research has led the way in expanding understanding of how genomic instability can lead to tumors and lymphomas. His work continues to unveil the complex mechanisms of chromosomal maintenance and the consequences of their inactivation.

"Fred Alt is one of the most inventive and perceptive scientists I know, said James Haber, director of the Rosenstiel Basic Medical Sciences Research Center at Brandeis. "His work has provided a framework on which many others have built to gain a deep understanding of the immune system and the sources of chromosomal translocations and amplifications in cancer."

Established in 1972, the Rosenstiel Award highlights the important role educational institutions play in encouraging and developing basic science. It is presented annually to leading scientists who have made discoveries of particular originality and importance to basic medical research. Many Rosenstiel winners have gone on to win the Lasker and Nobel Prizes.

The Rosenstiel Award for Distinguished Work in Biomedical Science consists of a cash prize and a medal. Alt will officially receive the award in a ceremony April 13, 2015.


Contact: Jarret Bencks
Brandeis University

Related biology news :

1. Brandeis scientists win prestigious prize for circadian rhythms research
2. Karl Deisseroth, Gero Miesenböck and Edward Boyden win Brandeis Gabbay Award in Biotechnology
3. Computer modeling technique goes viral at Brandeis
4. MARC travel awards announced for EB 2012
5. Autism Speaks awards $1.1 million to fund high priority studies
6. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
7. SEBM Distinguished Scientist Awards for 2012
8. SEBM Young Investigator Awards for 2012
9. SEBM Best Paper Awards for articles published in 2011
10. March of Dimes awards $250,000 prize to 2 scientists who pioneered advances in skin disorders
11. National Psoriasis Foundation awards more than $2 million for research
Post Your Comments:
(Date:9/15/2018)... ... September 14, 2018 , ... ... This campaign will showcase the innovative work being done within rare diseases research, ... therapies for those living with rare diseases. , The print ...
(Date:9/12/2018)... ... September 12, 2018 , ... Captiva Spine, Inc., which designs, ... received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ... , TowerLOX-EXT MIS Extended Tab Pedicle Screws provide the narrow insertion of an ...
(Date:9/1/2018)... ... ... Right this minute, Frenchman Ben Lecomte is hard at work on his second ocean crossing. ... a new challenge: going from Tokyo to San Francisco, churning his limbs eight hours a ... boat. As the first expedition of its kind, The Swim is far more than just ...
Breaking Biology News(10 mins):
(Date:9/7/2018)... , ... September 06, 2018 , ... ... compliance and commercialization, is releasing the agenda for its upcoming user conference. ... science industries discussing the latest challenges, opportunities, and approaches to regulatory compliance and ...
(Date:9/7/2018)... (PRWEB) , ... September 06, 2018 , ... Akadeum Life ... has spent his career as an executive and leader of numerous biotech companies. ... cell therapy and biologics company acquired by Thompson Street Capital in St. Louis, MO. ...
(Date:8/31/2018)... ASTORIA, Ore. (PRWEB) , ... August 29, 2018 ... ... holding Associate Professorships at both the University of Southampton and the Institute of ... and artificial intelligence at sea can dramatically accelerate the exploration and study of ...
(Date:8/29/2018)... CARMEL, Ind. (PRWEB) , ... August 28, 2018 ... ... company selling nano-technology enhanced spinal implants, announced today the successful completion of a ... 1st Source Capital Corporation, Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures. ...
Breaking Biology Technology: